Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Neuropathy in a 56 year-old woman].
Blaison F, Prudencio R, Laborde M, Baron JB, Salvado C, Legrain-Lifermann V, Dauzan Y, Le Bail B, Lifermann F, Lapoirie J. Blaison F, et al. Among authors: lifermann f. Rev Med Interne. 2024 Dec;45(12):784-786. doi: 10.1016/j.revmed.2024.06.016. Epub 2024 Aug 16. Rev Med Interne. 2024. PMID: 39153915 French. No abstract available.
[Aortic ulcer: an unusual aortitis].
Voinchet H, Lifermann F, Barlaud-Lestage V, Grenier N. Voinchet H, et al. Among authors: lifermann f. Rev Med Interne. 2004 May;25(5):397-9. doi: 10.1016/j.revmed.2004.01.014. Rev Med Interne. 2004. PMID: 15110960 French. No abstract available.
Nonischemic Cardiac Manifestations in VEXAS Syndrome.
Robert M, Mathian A, Lacombe V, Lobbes H, Adélaïde L, Le Besnerais M, Dacher JN, Terrier B, Mékinian A, Bourguiba R, Georgin-Lavialle S; FRENVEX Group. Robert M, et al. JAMA Netw Open. 2024 Dec 2;7(12):e2450251. doi: 10.1001/jamanetworkopen.2024.50251. JAMA Netw Open. 2024. PMID: 39666342 Free PMC article.
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis).
Pegoraro F, Papo M, Cohen-Aubart F, Peyronel F, Lugli G, Trambusti I, Baulier G, de Menthon M, Le Scornet T, Oziol E, Ferreira-Maldent N, Hermine O, Faucher B, Koschel D, Straetmans N, Abisror N, Terrier B, Lifermann F, Razanamahery J, Allenbach Y, Keraen J, Bulifon S, Hervier B, Buccoliero A, Charlotte F, Monzani Q, Boussouar S, Shor N, Tondo A, Barete S, Idbaih A, Tazi A, Sieni E, Amoura Z, Emile JF, Vaglio A, Haroche J. Pegoraro F, et al. Among authors: lifermann f. EClinicalMedicine. 2024 May 27;73:102658. doi: 10.1016/j.eclinm.2024.102658. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 38841707 Free PMC article.
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.
Hadjadj J, Nguyen Y, Mouloudj D, Bourguiba R, Heiblig M, Aloui H, McAvoy C, Lacombe V, Ardois S, Campochiaro C, Maria A, Coustal C, Comont T, Lazaro E, Lifermann F, Le Guenno G, Lobbes H, Grobost V, Outh R, Campagne J, Dor-Etienne A, Garnier A, Jamilloux Y, Dossier A, Samson M, Audia S, Nicolas B, Mathian A, de Maleprade B, De Sainte-Marie B, Faucher B, Bouaziz JD, Broner J, Dumain C, Antoine C, Carpentier B, Castel B, Lartigau-Roussin C, Crickx E, Volle G, Fayard D, Decker P, Moulinet T, Dumont A, Nguyen A, Aouba A, Martellosio JP, Levavasseur M, Puigrenier S, Antoine P, Giraud JT, Hermine O, Lacout C, Martis N, Karam JD, Chasset F, Arnaud L, Marianetti P, Deligny C, Chazal T, Woaye-Hune P, Roux-Sauvat M, Meyer A, Sujobert P, Hirsch P, Abisror N, Fenaux P, Kosmider O, Jachiet V, Fain O, Terrier B, Mekinian A, Georgin-Lavialle S; FRENVEX. Hadjadj J, et al. Among authors: lifermann f. Ann Rheum Dis. 2024 Sep 30;83(10):1358-1367. doi: 10.1136/ard-2024-225640. Ann Rheum Dis. 2024. PMID: 38777378
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.
Kosmider O, Possémé C, Templé M, Corneau A, Carbone F, Duroyon E, Breillat P, Chirayath TW, Oules B, Sohier P, Luka M, Gobeaux C, Lazaro E, Outh R, Le Guenno G, Lifermann F, Berleur M, Le Mene M, Friedrich C, Lenormand C, Weitten T, Guillotin V, Burroni B, Boussier J, Willems L, Aractingi S, Dionet L, Tharaux PL, Vergier B, Raynaud P, Ea HK, Ménager M, Duffy D, Terrier B. Kosmider O, et al. Among authors: lifermann f. Nat Commun. 2024 Jan 30;15(1):910. doi: 10.1038/s41467-024-44811-4. Nat Commun. 2024. PMID: 38291039 Free PMC article.
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry.
de Valence B, Delaune M, Nguyen Y, Jachiet V, Heiblig M, Jean A, Riescher Tuczkiewicz S, Henneton P, Guilpain P, Schleinitz N, Le Guenno G, Lobbes H, Lacombe V, Ardois S, Lazaro E, Langlois V, Outh R, Vinit J, Martellosio JP, Decker P, Moulinet T, Dieudonné Y, Bigot A, Terriou L, Vlakos A, de Maleprade B, Denis G, Broner J, Kostine M, Humbert S, Lifermann F, Samson M, Pechuzal S, Aouba A, Kosmider O, Dion J, Grosleron S, Bourguiba R, Terrier B, Georgin-Lavialle S, Fain O, Mekinian A, Morgand M, Comont T, Hadjadj J; French VEXAS Group. de Valence B, et al. Among authors: lifermann f. Ann Rheum Dis. 2024 Feb 15;83(3):372-381. doi: 10.1136/ard-2023-224819. Ann Rheum Dis. 2024. PMID: 38071510
Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials.
Delestre F, Charles P, Karras A, Pagnoux C, Néel A, Cohen P, Aumaître O, Faguer S, Gobert P, Maurier F, Samson M, Godmer P, Bonnotte B, Cottin V, Hanrotel-Saliou C, Le Gallou T, Carron PL, Desmurs-Clavel H, Direz G, Jourde-Chiche N, Lifermann F, Martin-Silva N, Pugnet G, Quéméneur T, Matignon M, Benhamou Y, Daugas E, Lazaro E, Limal N, Ducret M, Huart A, Viallard JF, Hachulla E, Perrodeau E, Puechal X, Guillevin L, Porcher R, Terrier B; French Vasculitis Study Group (FVSG). Delestre F, et al. Among authors: lifermann f. Ann Rheum Dis. 2024 Jan 11;83(2):233-241. doi: 10.1136/ard-2023-224623. Ann Rheum Dis. 2024. PMID: 37918894
Efficacy of daratumumab in refractory primary Sjögren disease.
Nocturne G, Marmontel O, di Filippo M, Chretien P, Krzysiek R, Lifermann F, Rahal N, Belkhir R, Moulin P, Mariette X. Nocturne G, et al. Among authors: lifermann f. RMD Open. 2023 Sep;9(3):e003464. doi: 10.1136/rmdopen-2023-003464. RMD Open. 2023. PMID: 37730313 Free PMC article. No abstract available.
98 results